Earlier diagnosis identified as key reason why more US women than Europeans survive breast cancerDecember 18, 2003The main reason why women diagnosed with breast cancer in the USA have higher survival than those in Europe is that they are diagnosed at an earlier stage, according to findings published today. Previous studies have shown that women in the US have higher breast cancer survival rates than women in Europe but, until now, scientists have been unable to pinpoint the reasons, suggesting that differences in treatment and access to healthcare might be a factor, but with little supporting evidence. In order to investigate further, an international team of researchers, including Professor Michel Coleman, Professor of Epidemiology and Vital Statistics at the London School of Hygiene & Tropical Medicine, analysed population-based data from 4,478 women included in the EUROCARE study (which examines cancer survival trends across Europe) and 13,182 women recorded in the US National Cancer Institute's SEER program from 1990-1992. Their findings will be published in the 15 February 2004 issue of CANCER, and also appear today on Wiley Interscience (www.interscience.wiley.com/cancer). Significantly more early-stage tumours were found among US women (41%) than among European women (29%). Elderly women in the USA were even more likely than younger women to be diagnosed at an early stage (43% of those aged 65 or more compared to 38% of under-65s). The opposite was true in Europe, where early-stage tumours were more common in younger women - 31% of under-65s and 25% of older women). Finally, overall 5-year survival was significantly higher among women in the USA than in Europe (89 per cent versus 79 per cent). Professor Michel Coleman commented: 'These findings reveal the urgent need to allocate more resources to ensure earlier diagnosis of breast cancer in Europe'. | |||||||||||||||||||||
|
Related Breast Cancer Current Events and Breast Cancer News Articles Angled gantry technique reduced breast radiation exposure by 50 percent A novel angled gantry approach to coronary CT angiography reduced radiation exposure to the breast by more than 50%, according to Thomas Jefferson University researchers. HER2 levels may aid in treatment selection for metastatic breast cancer Findings published in the December 1, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, show lapatinib benefits women with HER2-positive breast cancer, while women with HER2-negative breast cancer or those who express EGRF alone derive no incremental benefit. Drop in cancer deaths tied primarily to gains in behavior and screening Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University. New breast imaging technology targets hard-to-detect cancers Breast-specific gamma imaging (BSGI) is effective in the detection of cancers not found on mammograms or by clinical exam, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). Delays in Radiation Therapy Lead to Increased Breast Cancer Recurrence A new analysis of the National Cancer Institute's cancer registry has found that as many as one in five older women experience delayed or incomplete radiation treatment following breast-conserving surgery, and that this suboptimal care can lead to worse outcomes. New mammography technology effective in detecting breast cancer A study has found that positron emission mammography (PEM), a new technique for imaging the breast, is not affected by either breast density or a woman's hormonal status, two factors that limit the effectiveness of standard mammography and MRI at detecting cancer. New statistical model could help reduce breast-lesion biopsies A new method of characterizing breast lesions found during an MRI exam could result in fewer biopsies of benign tumors with the benefits of reduced pain and expense for patients and providers, according to a paper that will be presented today (Sunday, Nov. 30) at the annual meeting of the Radiological Society of North America (RSNA). Breast cancer treatment offers better outcome to women with implants Women with early-stage breast cancer who have undergone breast augmentation may be treated successfully with a partial-breast radiation treatment called brachytherapy, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). Study identifies double-balloon enteroscopy as cost-effective approach for obscure GI bleeding A cost-effectiveness analysis conducted by researchers at Stanford University Hospital in Calif., shows that an initial double-balloon enteroscopy (DBE) is a cost-effective approach for patients with obscure gastrointestinal (GI) bleeding. Study identifies causes of bone loss in breast cancer survivors Osteoporosis is a growing concern among breast cancer survivors and their doctors, because certain cancer drugs can cause bone loss. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||